SIMPLIFY-1+2 trial: What is the long-term benefit of momelotinib treatment in R/R MF? MPN Hub 4:04 3 years ago 167 Далее Скачать
Latest updates on momelotinib: safety, durability of response & survival benefit VJHemOnc – Video Journal of Hematology & HemOnc 3:02 1 year ago 449 Далее Скачать
An insight into the MOMENTUM trial: safety and efficacy of momelotinib for the treatment of MF VJHemOnc – Video Journal of Hematology & HemOnc 3:03 2 years ago 366 Далее Скачать
Analysis of long-term exposure to momelotinib in the Phase III SIMPLFY myelofibrosis trials VJHemOnc – Video Journal of Hematology & HemOnc 2:07 4 years ago 113 Далее Скачать
The promise of momelotinib in the treatment of myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 3:00 2 years ago 616 Далее Скачать
Recent updates from the MOMENTUM trial and the value of momelotinib for the treatment of MF VJHemOnc – Video Journal of Hematology & HemOnc 1:53 2 years ago 119 Далее Скачать
Updates on the use of momelotinib for the treatment of MF & clinical trials evaluating this agent VJHemOnc – Video Journal of Hematology & HemOnc 1:26 2 years ago 508 Далее Скачать
Long-term momelotinib exposure in JAKi-naïve or previously JAKi-treated myelofibrosis patients VJHemOnc – Video Journal of Hematology & HemOnc 2:28 4 years ago 102 Далее Скачать
Mechanism of Action of Momelotinib to Treat Myelofibrosis CheckRare 3:38 2 years ago 748 Далее Скачать
Long-term safety of momelotinib for myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 2:16 4 years ago 103 Далее Скачать
Transfusion-independence associated with OS in SIMPLIFY-1 and SIMPLFY-2 VJHemOnc – Video Journal of Hematology & HemOnc 1:58 3 years ago 44 Далее Скачать
Safety and anemia outcomes with momelotinib vs pacritinib in patients with myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 3:20 1 year ago 328 Далее Скачать
The latest data on momelotinib for MPNs VJHemOnc – Video Journal of Hematology & HemOnc 4:15 3 years ago 188 Далее Скачать
Phase 3 Trial of Momelotinib Versus Ruxolitinib in JAK Inhibitor Naive Patients with Myelofibrosis MPNUniversity .tv 4:20 7 years ago 159 Далее Скачать
Ruxolitinib, pacritinib, fedratinib or momelotinib for thrombocytopenic patients with myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 3:05 2 years ago 637 Далее Скачать
Indirect comparison of momelotinib vs pacritinib safety and anemia outcomes in myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 1:28 1 year ago 129 Далее Скачать
Update on momelotinib for myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 4:25 4 years ago 207 Далее Скачать
Momelotinib: a promising agent in MF VJHemOnc – Video Journal of Hematology & HemOnc 1:44 2 years ago 285 Далее Скачать
JAK inhibition for the early treatment of myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 3:48 3 years ago 752 Далее Скачать
The potential of momelotinib against myeloproliferative malignancies VJHemOnc – Video Journal of Hematology & HemOnc 2:19 7 years ago 147 Далее Скачать
